» Articles » PMID: 32912773

Genetic Iron Overload Disorders

Overview
Journal Mol Aspects Med
Date 2020 Sep 11
PMID 32912773
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Due to its pivotal role in orchestrating vital cellular functions and metabolic processes, iron is an essential component of the human body and a main micronutrient in the human diet. However, excess iron causes an increased production of reactive oxygen species leading to cell dysfunction or death, tissue damage and organ disease. Iron overload disorders encompass a wide spectrum of pathological conditions of hereditary or acquired origin. A number of 'iron genes' have been identified as being associated with hereditary iron overload syndromes, the most common of which is hemochromatosis. Although linked to at least five different genes, hemochromatosis is recognized as a unique syndromic entity based on a common pathogenetic mechanism leading to excessive entry of unneeded iron into the bloodstream. In this review, we focus on the pathophysiologic basis and clinical aspects of the most common genetic iron overload syndromes in humans.

Citing Articles

Nrf2 activators for the treatment of rare iron overload diseases: From bench to bedside.

Dong Y, Zheng M, Ding W, Guan H, Xiao J, Li F Redox Biol. 2025; 81:103551.

PMID: 39965404 PMC: 11876910. DOI: 10.1016/j.redox.2025.103551.


Iron homeostasis and ferroptosis in human diseases: mechanisms and therapeutic prospects.

Ru Q, Li Y, Chen L, Wu Y, Min J, Wang F Signal Transduct Target Ther. 2024; 9(1):271.

PMID: 39396974 PMC: 11486532. DOI: 10.1038/s41392-024-01969-z.


Copper ions: The invisible killer of cardiovascular disease (Review).

Wang Y, Feng L, Xu A, Ma X, Zhang M, Zhang J Mol Med Rep. 2024; 30(5).

PMID: 39301641 PMC: 11425066. DOI: 10.3892/mmr.2024.13334.


Iron Dysregulation in Cardiovascular Diseases.

Wang H, Huang Z, Du C, Dong M Rev Cardiovasc Med. 2024; 25(1):16.

PMID: 39077672 PMC: 11263000. DOI: 10.31083/j.rcm2501016.


Mechanism of ferroptosis regulating ischemic stroke and pharmacologically inhibiting ferroptosis in treatment of ischemic stroke.

Chai Z, Zheng J, Shen J CNS Neurosci Ther. 2024; 30(7):e14865.

PMID: 39042604 PMC: 11265528. DOI: 10.1111/cns.14865.